Stronger actions help treat senior COVID-19 patients in Hebei, Liaoning

Guo Yanhong, an official with the National Health Commission's medical supervision and administration department. [Photo/NHC Weibo]
Strong measures have been taken to treat senior COVID-19 patients in recent outbreaks in Hebei and Liaoning provinces, a senior health official said on Jan 13.
Guo Yanhong, an official with the National Health Commission's Medical Supervision and Administration Department, said 30 percent of COVID-19 patients in North China's Hebei and 37 percent of those in Northeast China's Liaoning are older than 60 and many have underlying conditions, such as cardiovascular disease.
The commission has dispatched national-level experts to work with local experts, and early intervention and monitoring have been provided to prevent mild patients progressing to severe cases, she said.
For severe COVID-19 patients, each patient has a team of multidisciplinary experts working out specific treatment plans for COVID-19 and other underlying diseases, she said.
The commission has allocated 30,000 ml of blood plasma of patients who are in the process of recovery to help treat patients in each of the two provinces, she added.
- Plan to boost eye care services by 2030
- China sees wider healthcare access as system continues to grow
- China moves to further improve family doctor services
- China targets better health for all by 2030
- China targets average life expectancy of 80 by 2030 in new five-year health plan
- The number of assisted reproductive institutions reaches 645 in China


